{"nctId":"NCT02845674","briefTitle":"An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca","startDateStruct":{"date":"2016-07-29","type":"ACTUAL"},"conditions":["Keratoconjunctivitis Sicca"],"count":258,"armGroups":[{"label":"OTX-101 0.09%","type":"EXPERIMENTAL","interventionNames":["Drug: OTX-101 0.09%"]}],"interventions":[{"name":"OTX-101 0.09%","otherNames":["Seciera"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Completion of Study OTX-101-2016-001\n\nExclusion Criteria:\n\n\\-","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Adverse Events","description":"Number of subjects reporting any AEs","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"81","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":129},"commonTop":["Instillation site pain","Conjunctival hyperaemia","Punctate keratitis","Vitreous detachment","Blepharitis"]}}}